ArticleBMC ophthalmology2025
Correlation analysis of the copy number of aqueous humor HSV DNA with anterior chamber reaction, topical steroid responsiveness and prognosis of endothelial herpes simplex keratitis.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
backgroundTo investigate the correlation between the copy number of herpes simplex virus (HSV) DNA in the aqueous humor and specific clinical parameters, including anterior chamber reaction, topical steroid responsiveness and prognosis in individuals with endothelial herpes simplex keratitis (EHSK).
methodsAn analysis of clinical data from 62 patients from June 2021 to June 2024, with herpetic keratitis was conducted, encompassing demographic characteristics, anterior chamber reaction, topical steroid responsiveness and prognosis. The copy number of HSV DNA in the aqueous humor was quantified. Correlation analysis was employed to assess associations between viral load and clinical parameters.
resultsThe high copy array group exhibited significantly higher anterior chamber cell count, anterior chamber flare level, corneal sensitivity compared to the control group. Additionally, the high copy array group showed a shorter time to resolution of inflammation after steroid treatment, higher likelihood of developing chronic HSV, and increased severity of corneal scarring. Correlation analysis revealed significant associations between the copy number of HSV DNA and various clinical parameters including anterior chamber reaction, topical steroid responsiveness and prognosis.
conclusionThe study elucidates significant associations between the copy number of HSV DNA in the aqueous humor and clinical parameters in individuals with EHSK. The findings highlight the potential value of viral load assessment in guiding clinical decision-making, personalized management strategies, and improving outcomes for affected individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.